These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 639508)

  • 1. Disopyramide--a new antiarrhythmic agent.
    Chow M
    Conn Med; 1978 Apr; 42(4):233-4. PubMed ID: 639508
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antiarrhythmic actions of disopyramide phosphate in patients with paroxysmal supraventricular tachycardia (author's transl)].
    Satoh M; Sada T; Kuan-Min S; Kira Y; Sekine I; Okabe F; Ueda A; Ito T; Matsumoto S
    Kokyu To Junkan; 1981 May; 29(5):537-44. PubMed ID: 7313358
    [No Abstract]   [Full Text] [Related]  

  • 3. A seminar on Norpace (disopyramide phosphate) a new antiarrhythmic agent. Introductory remarks.
    Turiel SN; Smith WS
    Angiology; 1975 Jan; 26(1 Pt 2):65-6. PubMed ID: 1115402
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug information: agents for the treatment of arrhythmia. Therapeutic main group: anti-arrhythmia agents. 10].
    Lumholtz IB
    Sygeplejersken; 1980 Oct; 80(42):11. PubMed ID: 6905440
    [No Abstract]   [Full Text] [Related]  

  • 5. [Disopyramide in the prevention of arrhythmia following myocardial infarction and resistant arrhythmia].
    Dallocchio M; Daubeze J; Clementy J; Poisot D; Bricaud H; Broustet P
    Therapie; 1974; 29(1):119-29. PubMed ID: 4848509
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effectiveness of propafenon and disopyramide in ventricular extrasystole. Comparative study].
    Kenedi P
    MMW Munch Med Wochenschr; 1982 Aug; 124(34):734-6. PubMed ID: 6182460
    [No Abstract]   [Full Text] [Related]  

  • 7. Disopyramide (Rythmodan) for arrhythmias?
    Drug Ther Bull; 1973 Jan; 11(1):3-4. PubMed ID: 4571419
    [No Abstract]   [Full Text] [Related]  

  • 8. [Correction of atrial fibrillation with disopyramide].
    Rullière R; Delepierre F
    Coeur Med Interne; 1972; 11(3):581-6. PubMed ID: 4636696
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
    J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical studies of Norpace (Part III).
    Kalmansohn RG
    Angiology; 1975 Jan; 26(1 Pt 2):137. PubMed ID: 1115400
    [No Abstract]   [Full Text] [Related]  

  • 11. [Disopyramide in heart arrhythmias].
    Pellegrino L; Di Michele A; Prencipe D
    Boll Soc Ital Cardiol; 1972; 17(8):617-25. PubMed ID: 4655948
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anti-arrhythmic action of disopyramide in comparison with that of quinidine].
    Poletti T; Aquaro G; D'Arrigo A; Pavia M
    Boll Soc Ital Cardiol; 1971; 16(9):591-600. PubMed ID: 5150385
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical studies of Norpace (Part VII).
    Berman R
    Angiology; 1975 Jan; 26(1 Pt 2):143. PubMed ID: 1090214
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical studies of Norpace (Part I).
    Smith WS
    Angiology; 1975 Jan; 26(1 Pt 2):124-31. PubMed ID: 1090212
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the efficacy of propafenone versus disopyramide for complex premature ventricular contractions. Evaluation with long-term monitoring.
    Naccarella F; Palmieri M; del Corso P; Lombardi G; Bracchetti D
    Arzneimittelforschung; 1982; 32(5):547-50. PubMed ID: 7201833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical studies of Norpace (Part II).
    Vismara L
    Angiology; 1975 Jan; 26(1 Pt 2):132-6. PubMed ID: 1090213
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical studies of Norpace (Part V).
    Cook WR
    Angiology; 1975 Jan; 26(1 Pt 2):140-1. PubMed ID: 1115401
    [No Abstract]   [Full Text] [Related]  

  • 18. The hemodynamic effects of Norpace. (Part II).
    Willis PW
    Angiology; 1975 Jan; 26(1 Pt 2):102-10. PubMed ID: 1115396
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical studies of Norpace (Part VIII).
    Laidlaw JC
    Angiology; 1975 Jan; 26(1 Pt 2):144-5. PubMed ID: 1090215
    [No Abstract]   [Full Text] [Related]  

  • 20. The hemodynamic effects of Norpace (Part I).
    Befeler B
    Angiology; 1975 Jan; 26(1 Pt 2):99-101. PubMed ID: 1115404
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.